Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat effects on insulin resistance and beta-cell function in hyperuricemia
ChiCTR-RIC-17011687Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of febuxostat in hyperuricemia (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Blood biochemical tests and Ultrasound. Planned start Jun 2017; status: not yet recruiting.
02
Drugs
febuxostat
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on ChiCTR-RIC-17011687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RIC-17011687.